Int J Clin Oncol 2021 Jun 10. Epub 2021 Jun 10.
Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato City, Tokyo, 105-8461, Japan.
Background: Several kinds of systemic inflammatory response, classified into two types: C-reactive protein (CRP)-based type and blood cell count-based type, were reported as a prognostic indicator in patients with pancreatic cancer (PC). However, there is no consensus which types is more sensitive predictor in patients with PC. Therefore, we here developed a novel biomarker, C-NLR, which consists of both CRP and neutrophil-to-lymphocyte ratio (NLR), and we evaluated the prognostic significance of C-NLR in patients with PC after pancreatic resection. Read More